{
  "id": "SCR-LIP-000626",
  "statement": "The main celiac-associated HLA-DQ haplotype is the principal genetic risk determinant for celiac disease, through presentation of gliadin peptides to helper T cells.",
  "claim_type": "clinical_association",
  "context": {
    "population": "patients with celiac disease",
    "condition": "lipedema",
    "exposure": "HLA-DQ2 genotype",
    "comparator": "—",
    "outcome": "celiac disease susceptibility",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "moderate",
  "evidence": [
    {
      "title": "The Association of HLA-DQ2 with Celiac Disease",
      "ref": "DOI:10.5772/intechopen.95837",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "moderate",
      "year": 2021,
      "amato_authored": false,
      "quote": "HLA-DQ2 é o principal determinante genético de risco para celíaca. Apresentação de gliadina por DQ2 a células T CD4+ central na patogênese.",
      "extraction_confidence": "high",
      "note": "The article reviews the HLA-DQ2–celiac disease association but makes no mention of lipedema; it is on-topic for the celiac/HLA component only and does not test any link to lipedema, so it provides background context rather than direct evide",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article directly states that HLA-DQ2 is the principal genetic risk determinant for celiac disease and that gliadin presentation by DQ2 to CD4+ T cells is central to pathogenesis, which matches the proposed statement exactly.",
        "date": "2026-11-17"
      },
      "stance_in_source_claim": "context",
      "finding": "Review describes HLA-DQ2 as the main genetic risk determinant for celiac disease, with DQ2 presentation of gliadin to CD4+ T cells central to its pathogenesis; lipedema is not discussed.",
      "from_claims": [
        "SCR-LIP-000467"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000467"
  ],
  "questions_consolidated": [
    "SQ-LIP-000009"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00126",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000009"
    }
  ],
  "statement_pt": "O principal haplótipo HLA-DQ associado à doença celíaca é o principal determinante genético de risco para a doença celíaca, por meio da apresentação de peptídeos de gliadina a linfócitos T auxiliares.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000009",
      "role": "context",
      "question": "Is lipedema linked to gluten sensitivity, celiac disease, or HLA-DQ2/DQ8?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000009.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000626.html"
}